World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
31331
World Ranking
19753
National Ranking
666

Bernard Nordlinger publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bernard Nordlinger sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 255 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bernard Nordlinger D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bernard Nordlinger sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bernard Nordlinger is affiliated with Assistance Publique - Hôpitaux de Paris in France and has contributed extensively to the field of medicine, particularly within oncology, surgery, and hepatology. Their research spans multiple subfields including oncology, public health, environmental and occupational health, surgery, hepatology, and general health professions.

The scientist's primary research topics include colorectal cancer treatments and studies, hepatocellular carcinoma treatment and prognosis, global health and surgery, artificial intelligence in healthcare and education, colorectal cancer surgical treatments, colorectal and anal carcinomas, and pancreatic and hepatic oncology research.

Recent publications authored or co-authored by Bernard Nordlinger include the following:

  • "Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD" (2020) published in Journal of Clinical Oncology
  • "Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases" (2021) published in The Journal of Pathology Clinical Research
  • "Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)" (2020) published in European Journal of Surgical Oncology
  • "Rapport 24-03. Systèmes d'IA générative en santé: enjeux et perspectives" (2024) published in Bulletin de l Académie Nationale de Médecine
  • "Chirurgie et intelligence artificielle: c'est pour bientôt?" (2021) published in Journal de Chirurgie Viscérale

Bernard Nordlinger frequently collaborates with several co-authors, among whom are Murielle Mauer, Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, and Timothy Price.

The scientist has published in a range of academic venues, including:

  • Journal of Clinical Oncology
  • The Journal of Pathology Clinical Research
  • European Journal of Surgical Oncology
  • Bulletin de l Académie Nationale de Médecine
  • Journal de Chirurgie Viscérale

Their body of work addresses complex issues in colorectal cancer treatments, liver metastases, and the emerging interface of artificial intelligence with surgical techniques and healthcare systems. This multidisciplinary approach encompasses both clinical oncology and broader public health challenges.

Best Publications

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Labianca;B. Nordlinger;G. D. Beretta;S. Mosconi

  • Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    E. Van Cutsem;A. Cervantes;B. Nordlinger;D. Arnold

  • Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

    Arnaud D. Roth;Sabine Tejpar;Mauro Delorenzi;Pu Yan

  • Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

    Christoph Schuhmacher;Stephan Gretschel;Florian Lordick;Peter Reichardt

  • Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC).

    André Gerard;Marc Buyse;Bernard Nordlinger;Jean Loygue

  • Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

    Eric Van Cutsem;Bernard Nordlinger;Rene Adam;Claus-Henning Köhne

  • Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?

    Stéphane Benoist;Antoine Brouquet;Christophe Penna;Catherine Julié

  • Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group

    Udo Vanhoefer;Philippe Rougier;Hansjochen Wilke;Michel P. Ducreux

  • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.

    Guillaume Portier;Dominique Elias;Olivier Bouche;Philippe Rougier

  • Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

    Theo Ruers;Frits Van Coevorden;Cornelis J. A. Punt;Jean-Pierre E. N. Pierie

  • Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Eric Van Cutsem;Roberto Labianca;György Bodoky;Carlo Barone

  • Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment.

    E. Van Cutsem;B. Nordlinger;A. Cervantes

  • Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

    T. Ruers;C. Punt;F. Van Coevorden;J. P. E. N. Pierie

  • Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

    R. Labianca;B. Nordlinger;G. D. Beretta;A. Brouquet

  • Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

    B. Nordlinger;E. Van Cutsem;T. Gruenberger;Bengt Glimelius;Bengt Glimelius

  • Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

    Bernard Nordlinger;Eric Van Cutsem;Philippe Rougier;Claus Henning Köhne

  • OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer

    Graeme J. Poston;René Adam;Steven Alberts;Steven Curley

  • 6010 POSTER DISCUSSION Radiofrequency Ablation Combined With Systemic Treatment Versus Systemic Treatment Alone in Patients With Non- Resectable Colorectal Liver Metastases: a Randomized EORTC Intergroup Phase II Study (EORTC 40004)

    T. Ruers;C. Punt;F. van Coevorden;J. Ledermann

Frequent Co-Authors

Bengt Glimelius
Bengt Glimelius Uppsala University
Roberto Labianca
Roberto Labianca Mario Negri Institute for Pharmacological Research
John R. Zalcberg
John R. Zalcberg Monash University
Peter M. Schlag
Peter M. Schlag Charité - University Medicine Berlin
Wolf O. Bechstein
Wolf O. Bechstein Goethe University Frankfurt
Daniel G. Haller
Daniel G. Haller University of Pennsylvania
Andrés Cervantes
Andrés Cervantes University of Valencia
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA offers more than just the traditional MD route. Many students consider entry-level nursing degrees as accessible options. If you’re seeking a fast track, entry level msn programs online are a great way for non-nurses to transition into advanced nursing roles efficiently.

For those interested in less competitive admissions, you may wonder whats the easiest nursing program to get into?. Several schools offer flexible acceptance criteria for aspiring nurses. Alternatively, those wanting a pathway without standardized entrance tests can look for an lpn program no entrance exam.

If you prefer a non-clinical healthcare role, consider medical billing and coding. Plenty of medical billing and coding schools online with financial aid can help you enter this growing field at your own pace.

These online programs open the door to rewarding healthcare careers without the long commitment and competitive admissions of traditional medicine.

Best Scientists Citing Bernard Nordlinger

Trending Scientists

Recently Published Articles